The Supreme Court has sharply rebuked the overpricing of essential cancer drugs, calling it a 'broad daylight dacoity' against patients. It noted that the MRP of one drug (₹27,000) was 10 times its price to retailer (₹2,700), and expressed shock over the silence of regulatory authorities.
Exam Lens
Quick Exam Facts From News
1-Minute Revision
- ›SC Bench: Justices Vikram Nath and Sandeep Mehta
- ›Drug MRP vs Price to Retailer: ₹27,000 vs ₹2,700 (10x)
- ›Target this Data: MRP ₹27,000 vs PTR ₹2,700 (10x markup for essential cancer drug)
- ›Target this Nodal Body: Supreme Court Bench (Justices Vikram Nath and Sandeep Mehta)
- ›Target this Legal Point: Drugs (Prices Control) Order, 2013
Mastered this topic? Test your knowledge with a full MCQ quiz.
Practice exam-style questions, track your score, and strengthen your recall.